To overcome the scarcity of endocrine *β* cells for cell replacement therapy in patients with type 1 diabetes, additional sources of transplantable *β* cells are needed. Reprogramming of non-endocrine pancreatic cells into *β* cells offers one attractive approach. Exocrine cells comprise the vast majority of cells obtained from cadaveric donor pancreases, but are discarded following isolation of the endocrine islets, and thus could provide a large pool of cells for conversion to *β* cells.

Historically pancreatic duct cells have been favored as the potential source of new islet *β* cells owing to histological observations in the developing and adult human pancreas showing close association of duct and endocrine cells,^[@bib1],\ [@bib2]^ with cells detected expressing both duct and *β-*cell markers. Purification of human duct cells based on CA19.9 expression and subsequent 3D *in vitro* culture was shown to yield a limited number of insulin^+^ cells with an immature glucose-induced insulin response.^[@bib3],\ [@bib4]^ These reports have been contested later on suggesting that dedifferentiated islet *β* cells may have been the source of these new insulin^+^ cells,^[@bib5]^ leaving the differentiation potential of human exocrine duct cells currently unanswered.

Pancreatic acinar cells represent an alternative attractive population for exocrine-to-endocrine transdifferentiation owing to their abundance and potential for plasticity. Rodent pancreatic acinar cells are shown to exhibit phenotypic instability *in vitro* and undergo a spontaneous ductal metaplasia following isolation.^[@bib6],\ [@bib7]^ These metaplastic acinar cells can adopt a duct-,^[@bib6],\ [@bib8]^ hepatocyte-^[@bib9]^ and *β*-like phenotype,^[@bib8],\ [@bib10],\ [@bib11],\ [@bib12]^ depending on the stimuli provided. In contrast, similar plasticity has not been demonstrated for human pancreatic acinar cells, although they can undergo spontaneous metaplasia to duct-like cells *in vitro*^[@bib3]^ similar to what is observed in rodents. We previously showed that supplementation of the medium of cultured rat acinar cells with EGF and LIF^[@bib8],\ [@bib10],\ [@bib14]^ and triggering MAPK (mitogen-activated protein kinase) and STAT3 (signal transducer and activator of transcription 3) signal transduction^[@bib14]^ converts them to *β*-like cells. Therefore, we hypothesized that ectopic signaling through MAPK and STAT3 might convert human acinar cells to *β*-like cells as well. The current study shows that ectopic expression of activated MAPK and STAT3 in human pancreatic acinar cells activates the proendocrine transcription factor neurogenin 3 (Neurog3) and reprograms human acinar cells to insulin-positive *β*-like cells able to ameliorate chemical diabetes.

Results
=======

Overexpression of MAPK^CA^ and STAT3^CA^ activates an endocrine differentiation program in monolayers of cultured exocrine cells
--------------------------------------------------------------------------------------------------------------------------------

Pancreatic cell populations consisting of acinar, centroacinar, duct and few endocrine/mesenchymal cells from human donor pancreata were transduced with LeMS^CA^, a bicistronic lentivirus constitutively overexpressing active MAPK and STAT3, and subsequently cultured as adherent monolayers ([Figure 1a](#fig1){ref-type="fig"}). In the LeMS^CA^-infected cell cultures, the levels of *NEUROG3*, *PAX4* and *NKX2.2*, mRNAs encoding transcription factors functioning in endocrine progenitor cells, were increased compared with control-transduced cells (LeGFP) ([Figure 2a](#fig2){ref-type="fig"}, protocol 1). *NKX6.1* mRNA, however, significantly decreased and *INS* (insulin) mRNA remained similar to control. At a transduction efficiency of 48.1±2.1% (*n*=4), Ngn3 protein was detected in 38.3±1.4% (*n*=4) of total exocrine cells ([Figure 2d](#fig2){ref-type="fig"}). A small fraction of the Ngn3^+^cells coexpressed Pdx1 (pancreatic and duodenal homeobox 1) protein (7.6±0.8% *n*=4), but insulin^+^ cells were not increased ([Figure 2e](#fig2){ref-type="fig"}). All Ngn3^+^ and Pdx1^+^ cells analyzed coexpressed GFP (green fluorescent protein), indicating the presence of LeMS^CA^ virus. In control LeGFP-transduced cells, no Ngn3 or Pdx1 expression was detected ([Supplementary Figures S1A and B](#sup1){ref-type="supplementary-material"}).

LeMS^CA^-transduced cells also contained higher levels of mRNA encoding acinar cell-specific markers relative to LeGFP-transduced cells ([Figure 2b](#fig2){ref-type="fig"}, protocol 1), despite similar marked decreases in phenotypically stable acinar cells in both cultures ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). In LeMS^CA^ cells, the levels of ductal mRNAs *FOXA2* and *SOX9* were significantly decreased ([Figure 2c](#fig2){ref-type="fig"}, protocol 1), whereas the expression of ONECUT1, a previously described regulator of Neurog3 expression in rodents,^[@bib15]^ was increased ([Figure 2c](#fig2){ref-type="fig"}, protocol 1). All cells, independent of their state of transduction, expressed the duct markers Krt19 (cytokeratin 19) and Sox9 by immunostaining, but no acinar cell-specific proteins ([Supplementary Figure S1D](#sup1){ref-type="supplementary-material"}).

In an attempt to increase endocrine differentiation, we examined the effect of overexpressing either MAPK^CA^ (M^CA^) or STAT3^CA^ (S^CA^) alone before the combination of MAPK^CA^+STAT3^CA^ (MS^CA^). Three days of STAT3^CA^ followed by 7 days of MS^CA^ (LeS^CA^~3d~MS^CA^~7d~) did not further increase Ngn3 expression and lowered Pdx1 expression as compared with LeMS^CA^ only ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}). However, overexpression of MAPK^CA^ before MS^CA^ (LeM^CA^~3d~MS^CA^~7d~) markedly increased endocrine gene expression ([Figures 1b](#fig1){ref-type="fig"} and [2a](#fig2){ref-type="fig"}, protocol 2). Compared with LeMS^CA^ cells ([Figure 2a](#fig2){ref-type="fig"}, protocols 1 and 2), the amount of *NKX6.1*, *PDX1* and *INS* mRNA significantly increased in LeM^CA^~3d~MS^CA^~7d~ suggestive of the ongoing *β*-cell differentiation (*n*=9; *P*\<0.01). Although the number of Ngn3^+^ cells remained similar (39.9±2.4% *versus* 38.3±1.4% in LeMS^CA^ cells) ([Figures 1d--f](#fig1){ref-type="fig"}), the number of LeM^CA^~3d~MS^CA^~7d~ cells with Pdx1 protein was increased (28.0±2.5% *versus* 7.6±0.8% LeMS^CA^ cells; [Figures 2e and f](#fig2){ref-type="fig"}), indicating that pre-treatment with MAPK^CA^ did not hamper the activation of a proendocrine program. However, despite the presence of high endogenous Pdx1, the number of hormone-producing cells did not increase ([Figure 2d](#fig2){ref-type="fig"}).

The expression level of acinar cell-specific mRNAs was comparable in LeMS^CA^ and LeM^CA^~3d~MS^CA^~7d~ cells ([Figure 2b](#fig2){ref-type="fig"}). The expression of *ONECUT1* mRNA was markedly increased in LeM^CA^~3d~MS^CA^~7d~ cells, whereas *FOXA2* transcripts significantly decreased. The majority of Pdx1^+^ cells still displayed a duct-like phenotype, expressing Krt19 and Sox9, the latter at low levels ([Supplementary Figure S2B](#sup1){ref-type="supplementary-material"}).

Ectopic expression of MAPK^CA^ and STAT3^CA^ thus demonstrates the potential of human exocrine cells to respond to this specific signaling by initiating a proendocrine differentiation program, similar to what has been described previously in rodent cells,^[@bib8],\ [@bib10],\ [@bib14]^ albeit without the ability to complete endocrine differentiation under these conditions.

Transplantation of human exocrine cells overexpressing MS^CA^ allows for further endocrine differentiation of 2D exocrine cell cultures
---------------------------------------------------------------------------------------------------------------------------------------

As endocrine progenitor cells have already been shown to mature *in vivo* to functional *β* cells,^[@bib16]^ we evaluated the capacity of an *in vivo* environment to provide critical maturation signals missing *in vitro*. Following monolayer culture, LeM^CA^~3d~MS^CA^~7d~ or LeGFP cells were transplanted under the kidney capsule of immunocompromised mice to study their potential for maturation to endocrine cells ([Figure 1b](#fig1){ref-type="fig"}). When harvested 42 days after engraftment, very few Neurog3^+^ cells remained ([Figures 3a and d](#fig3){ref-type="fig"}), whereas the number of Pdx1^+^ cells persisted (*n*=5) and Krt19^+^ cells marginally decreased (84.3±2.6% *versus* 92.7±0.8% before transplantation) ([Figure 3d](#fig3){ref-type="fig"}). The LeM^CA^~3d~MS^CA^~7d~ grafts contained both glucagon^+^ ([Figure 3b](#fig3){ref-type="fig"}) cells and insulin^+^ cells ([Figure 3c](#fig3){ref-type="fig"}) but the LeGFP grafts did not. The number of insulin^+^ cells significantly increased following engraftment (0.44±0.06% before *versus* 1.17±0.20% after transplantation; *P*\<0.05) ([Figures 3c and d](#fig3){ref-type="fig"}), whereas no insulin^+^ cells were observed among grafted LeGFP cells. The insulin^+^ cells did not stain for Krt19 but only a few displayed nuclear MafA, indicative of incomplete maturation to functional *β* cells.^[@bib17],\ [@bib18]^ Rare insulin^−^MafA^+^ cells were observed. Taken together, these observations resemble the transient expression of Ngn3 during pancreas development and support the hypothesis that engraftment of LeM^CA^~3d~MS^CA^~7d~ exocrine cells from human pancreas further stimulates endocrine differentiation.

Overexpression of MS^CA^ promotes endocrine differentiation in human exocrine 3D cultures
-----------------------------------------------------------------------------------------

In an attempt to reproduce the endocrine cell differentiation observed *in vivo* in cultured cells and knowing that exocrine LeM^CA^~3d~MS^CA^~7d~ cells in 2D culture did not differentiate efficiently, we cultured the cells in 3D matrix for 8 days (LeMS^CA^~3D~) ([Figure 1c](#fig1){ref-type="fig"}), which promotes alterations in cell polarity and cell--cell contact that stimulate differentiation.^[@bib19],\ [@bib20],\ [@bib21]^ Because suspension culture of rodent acinar cells allows their dedifferentiation (rather than transdifferentiation to duct-like cells) and subsequent differentiation to insulin^+^ cells,^[@bib8],\ [@bib22]^ we examined the effects of suspension preculture by keeping freshly isolated, lentivirus-transduced exocrine cells in free-floating suspension culture for 10 days followed by 3D matrix culture for 8 days (LeMS^CA^~FF/3D~) ([Figure 1d](#fig1){ref-type="fig"}).

LeMS^CA^~3D~ and LeMS^CA^~FF/3D~ cells contained significantly more *NEUROG3* and *NEUROD1* mRNA compared with LeGFP~3D~ cells, whereas the level of *PDX1* and *INS* transcripts remained similar ([Figure 4a](#fig4){ref-type="fig"}). Compared with LeGFP~FF/3D~, LeMS^CA^~FF/3D~ cells contained significantly more *NKX6.1*, *NEUROD1* and *ISL1* transcripts (*P*\<0.05). A significant increase in NEUROD1 expression was already observed in the LeMS^CA^~3D~ culture condition; however, this increase is even more pronounced in LeMS^CA^~FF/3D~, suggesting improved endocrine differentiation, a conclusion supported by increased abundance of insulin transcripts and protein when a free-floating culture period was included ([Figures 4a and e](#fig4){ref-type="fig"}).

Compared with LeGFP control cells, the levels of duct cell-specific transcripts did not change ([Figure 4b](#fig4){ref-type="fig"}). All cells expressed Krt19 at the protein level ([Figures 4c and e](#fig4){ref-type="fig"}). The acinar cell-specific transcript *PTF1A* (pancreas-specific transcription factor 1a) increased in LeMS^CA^ cells ([Figure 4b](#fig4){ref-type="fig"}) without an associated rise in the mRNA encoding acinar cell-specific proteins amylase, chymotrypsin, Mist1 and Ptf1a.

Neurog3^+^ cells were detected in LeMS^CA^~3D~ (4.6±1.3%) and LeMS^CA^~FF/3D~ (7.7±3.0%) but not in LeGFP~3D~ or LeGFP~FF/3D~ cultures ([Figures 4c and d](#fig4){ref-type="fig"}). The number of Pdx1^+^ cells was significantly increased in both LeMS^CA^~3D~ (10.7±2.0%, *P*\<0.01) and LeMS^CA^~FF/3D~ cells (6.1±2.6%, *P*\<0.05) as compared with LeGFP control cells ([Figures 4d and f](#fig4){ref-type="fig"}); and insulin^+^ cells were even more markedly increased in LeMS^CA^~FF/3D~ cells (7.3±2.6% (*n*=7)) *versus* LeMS^CA^~3D~ (0.83±0.40% in (*n*=8)) and LeGFP~FF/3D~ (0.06±0.06% (*n*=10); *P*\<0.05) ([Figures 4d and f](#fig4){ref-type="fig"}).

*KRT19*, *PTF1A* and *NEUROG3* mRNA levels were confirmed by conventional reverse transcription-PCR and indicate that the acinar cells do adopt a duct-like phenotype during culture ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}), as previously reported,^[@bib13],\ [@bib23]^ and that at least a sub-population of LeMS^CA^~FF/3D~ cells initiate an endocrine differentiation program ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). Unlike the pre-existing *β* cells, the insulin^+^ LeMS^CA^~FF/3D~ cells did not stain for MafA by immunohistochemistry (IHC), suggesting that the newly formed insulin^+^ cells are not fully mature ([Supplementary Figure S4A](#sup1){ref-type="supplementary-material"}). The new insulin^+^ cells did not derive by proliferation of pre-existing *β* cells: no insulin^+^ cells expressed the proliferation marker Ki67 ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}).

Unlike the exocrine cell cultures, transduction of human islets with LeMS^CA^ did not activate the expression of Neurog3 ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). In addition, both transduced (GFP^+^) and non-transduced (GFP^−^) *β* cells expressed MafA, Pdx1 and insulin, showing that viral transduction does not prevent their expression.

Short-term transplantation of LeMS^CA^~FF~ cells promotes endocrine differentiation
-----------------------------------------------------------------------------------

Because the LeMS^CA^~FF/3D~-transduced human exocrine cells yielded the most efficient endocrine differentiation, we tested whether substituting 3D culture by engraftment could further improve the efficiency of differentiation. LeMS^CA^~FF~ or LeGFP~FF~ cells were transplanted under the kidney capsule of immunocompromised mice and 42 days later the graft-bearing kidney was harvested for analysis ([Figure 1e](#fig1){ref-type="fig"}). The amount of GFP^+^insulin^+^ cells strongly increased in LeMS^CA^~FF~ grafts compared with LeGFP~FF~ controls ([Figures 5a and d](#fig5){ref-type="fig"}). The grafts showed a near total loss of Ngn3^+^ cells, while Pdx1 was present in all human cells ([Figures 5b and d](#fig5){ref-type="fig"}). A markedly higher expression of Pdx1 was observed in 4.2±0.7% cells of LeMS^CA^~FF~ grafts (Pdx1^high^ cells), a significant increase (*P*\<0.001; *n*=5) compared with control grafts and concordant with transplanted LeMS^CA^ cells after 2D culture. The majority of the grafted cells are Krt19^+^, except for the hormone^+^ cells ([Figures 5a and c](#fig5){ref-type="fig"}). The fraction of insulin^+^ cells increased significantly (5.6±1.1% in LeMS^CA^~FF~ *versus* 0.5±0.3% in LeGFP~FF~; *P*\<0.001, *n*=10) ([Figure 5d](#fig5){ref-type="fig"}) and was similar to that obtained in LeMS^CA^~FF/3D~ cells *in vitro* ([Figure 4e](#fig4){ref-type="fig"}). In absolute numbers, however, the yield of insulin^+^ cells remained rather low.

New human *β* cells derived from reprogrammed acinar cells
----------------------------------------------------------

For unbiased tracing of the fate of the insulin^+^ LeMS^CA^~FF/3D~ cells, a lentivirus-mediated, Cre-lox-based reporter expression was used. First, infection with Ad*Cela2A*^Cre^ virus ensured acinar-specific expression of Cre recombinase under the control of the elastase 2A gene promoter. When combined with a second virus that, upon Cre-mediated excision of the loxSTOPlox (LSL) signal, constitutively expressed a DsRed reporter under the control of the cytomegalovirus promoter (Le*CMV*-LSL-DsRed), acinar cells could be permanently traced ([Figure 1f](#fig1){ref-type="fig"}). The fate of acinar cells from human pancreas was traced in LeMS^CA^~FF/3D~ cells as these showed the most efficient endocrine differentiation. The analysis was performed on cells coexpressing the lineage tracer DsRed and the LeGFP- or LeMS^CA^-derived GFP ([Figure 6a](#fig6){ref-type="fig"}). Insulin^+^DsRed^+^ (20.8±1.4% of all insulin^+^ cells; *n*=4) or Neurog3^+^DsRed^+^ (16.3±1.1% of all Ngn3^+^ cells; *n*=4) cells were readily detected among LeMS^CA^~FF/3D~ but never among LeGFP~FF/3D~ cells ([Figures 6a and b](#fig6){ref-type="fig"}). Acinar cells can thus be reprogrammed to insulin^+^ cells when transduced with activated MAPK and STAT3 and cultured under free-floating/3D conditions. These observations demonstrate the plasticity of acinar cells and indicate that under appropriate conditions human acinar cells can be respecified to insulin^+^ cells following transient expression of Neurog3.^[@bib14]^

Long-term engraftment of LeMS^CA^~FF~ cells generates functional grafts capable of producing c-peptide and responding to increased glucose levels
-------------------------------------------------------------------------------------------------------------------------------------------------

Following engraftment of LeMS^CA^~FF~ cells under the kidney capsule of immunocompromised mice ([Figure 1e](#fig1){ref-type="fig"}), a significant rise in circulating human c-peptide could be observed from day 90 onwards ([Figure 7a](#fig7){ref-type="fig"}) (*n*=4; *P*\<0.05), whereas control mice never show a change in c-peptide levels. Injection of alloxan to destroy the endogenous rodent *β* cells further increased the basal circulating c-peptide in LeMS^CA^~FF~ mice. Before alloxan injection, the blood glucose levels in LeMS^CA^~FF~ and LeGFP~FF~ mice were similar. Following destruction of the endogenous *β* cells, LeGFP~FF~ mice displayed a sharp increase in glycemia, whereas LeMS^CA^~FF~ mice were able to attenuate and partially control the expected rise in blood glucose levels (on day 206 16.6±0.5 mmol/l in LeMS^CA^~FF~ *versus* 32.7±0.3 mmol/l in LeGFP~FF~; *P*\<0.01, *n*=6) ([Figure 7b](#fig7){ref-type="fig"}). Upon nephrectomy of the graft-bearing kidney, LeMS^CA^~FF~ mice became severely hyperglycemic and indistinguishable from controls (on day 212, 31.9±0.6 mmol/l in LeMS^CA^~FF~ *versus* 33.0±0.2 mmol/l in LeGFP~FF~; *P*\>0.05, *n*=6). Intraperitoneal glucose tolerance test performed on day 208 demonstrated improved glucose tolerance of LeMS^CA^~FF~ mice compared with LeGFP~FF~ mice. LeMS^CA^~FF~ mice remained, however, more glucose intolerant compared to mice with mature human islet grafts (especially at 90 and 120 min postglucose injection) (*n*=6; *P*\<0.05) ([Figure 7c](#fig7){ref-type="fig"}). Isolated grafts showed glucose responsiveness *in vitro* with a fivefold increase in secreted insulin levels when comparing low *versus* high glucose conditions (*n*=3; *P*\<0.05) ([Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}). The *β*-like cells in the grafts, did not proliferate (0.1±0.03% Ki67^+^insulin^+^ cells in LeMS^CA^~FF~ grafts; *n*=6) ([Supplementary Figure S6B](#sup1){ref-type="supplementary-material"}). However, graft functionality was further demonstrated by serial transplantation with retrieved grafts able to attenuate blood glucose levels in secondary recipient mice ([Supplementary Figure S6C](#sup1){ref-type="supplementary-material"}).

Long-term engraftment of LeMS^CA^~FF~ cells generates insulin^+^ islet-like clusters
------------------------------------------------------------------------------------

Engraftment of LeMS^CA^~FF~ cells under the kidney capsule of immunocompromised mice during 210 days generates stable grafts readily detectable by GFP expression ([Figure 7d](#fig7){ref-type="fig"}). Upon closer examination, a substantial amount of insulin^+^ cells was detected (8.0±0.1% *n*=6) ([Figure 7e](#fig7){ref-type="fig"}). Whereas 29.6±1.2% of all cytokeratin 19+ cells contained GFP, indicating the expression of activated MAPK and STAT3 (*n*=6), insulin^+^ cells seemed to have a higher prevalence of GFP (65.5±9.0% GFP^+^insulin^+^ cells; *n*=6) ([Figures 7e and f](#fig7){ref-type="fig"}). In addition, acinar-specific genetic lineage tracing (Ad*Cela2A*^Cre^/Le*CMV*-LSL-LacZ) ([Figure 1f](#fig1){ref-type="fig"}) revealed that although 27.1±1.2% of Krt19^+^ cells (*n*=6) contained the acinar *β*-galactosidase (*β*gal) label, the fraction of insulin^+^ cells expressing this genetic tracer was significantly higher (61.7±8.8% *n*=6)([Figures 7e and f](#fig7){ref-type="fig"}). Insulin^+^ cells were organized in islet-like clusters and expressed high levels of Pdx1 ([Figure 7f](#fig7){ref-type="fig"}).

Discussion
==========

Rodent acinar cells demonstrate a remarkable plasticity in culture that can be manipulated to transdifferentiate them to insulin^+^ cells for replacement therapy in diabetes. This reprogramming can be induced in cultured acinar cells from rat and mice by the combination of, respectively, EGF+LIF^[@bib8]^ and EGF+nicotinamide^[@bib24]^ and *in vivo* in mouse pancreas by ectopic expression of three transcription factors, Neurog3, Pdx1 and MafA^[@bib25]^ or by EGF+CNTF treatment of diabetic mice.^[@bib26]^ In the present study, we focus on translating these original findings from rodent to man. We hypothesized that MAPK and STAT3 signaling, known effectors of EGF and LIF, may regulate the dedifferentiation of human acinar cells to a progenitor state and the subsequent redifferentiation to endocrine cells.^[@bib10],\ [@bib14]^

Our data indicate that human acinar cells can undergo reprogramming upon introduction of activated MAPK+STAT3 (MS^CA^). In accordance with previous reports,^[@bib13],\ [@bib22]^ acinar cells rapidly lost their identity during *in vitro* culture and the majority adopted a phenotype resembling pancreatic duct cells. However, in contrast to earlier studies, the key developmental transcription factor Neurog3^[@bib27],\ [@bib28],\ [@bib29]^ was re-expressed in MS^CA^ cells. The expression of Neurog3 was transient when MS^CA^ cells were transplanted. When human exocrine cells were transduced with MS^CA^ and cultured as 2D monolayers, they initiated a proendocrine differentiation program. The endocrine differentiation was not completed, however, as the amount of insulin^+^ and glucagon^+^ cells did not increase. Compared with culture in free-floating aggregates,^[@bib30]^ exocrine cells in 2D lost their Pdx1 expression, but by sequential transduction with LeMAPK and LeSTAT3, the number of Pdx1^+^ cells in 2D cultures increased again. By altering the culture conditions from 2D monolayer to 3D Matrigel, we observed enhanced endocrine differentiation of MS^CA^ cells. Other studies have previously reported that alterations in cell polarity and cell--cell contact positively affect cell differentiation.^[@bib19],\ [@bib20]^ By combining free-floating culture with 3D Matrigel culture, we further stimulated endocrine differentiation as illustrated by increased numbers of Neurog3^+^ and Pdx1^+^insulin^+^ cells. The appearance of insulin^+^ cells indicates that under these conditions of culture human exocrine cells transduced with MS^CA^ are prone to terminal endocrine differentiation rather than acinoductal transdifferentiation. Possibly the free-floating preculture allows the acinar cells to adopt a state similar to embryonic pancreas progenitors, making these cells more susceptible to proendocrine signaling.^[@bib30]^ In contrast to previous reports,^[@bib31],\ [@bib32]^ the presence of activated MAPK did not activate the cell cycle as the fraction of proliferating cells was low in these cultures and did not differ from control cells.

When adult islet *β* cells were subjected to LeMS^CA^~FF/3D~ treatment, Neurog3 expression was not activated. In addition, the expression of insulin, MafA and Pdx1 in adult islet *β* cells was not influenced by LeMS^CA^. These observations confirm the hypothesis that activated MAPK and STAT3 can convert human exocrine cells into *β*-like cells, and pre-existing *β* cells are unlikely to be the source of the Neurog3^+^ or newly formed insulin^+^ cells.

Engraftment of LeMS^CA^~FF~ cells during an extended period of 210 days allowed the cells to acquire functionality. Under normoglycemic conditions, these mice displayed an increase in circulating human c-peptide starting around day 90 postengraftment. Upon chemical destruction of the endogenous rodent *β* cell population, c-peptide levels further spiked and the sharp increase in blood glucose levels in controls was attenuated in LeMS^CA^~FF~ mice. In addition these animals showed an improved glucose tolerance, suggesting that these LeMS^CA^~FF~ cells formed stable grafts able to respond to change in glycemia. Removal of the graft unequivocally identified the human cells as source of c-peptide and control over blood glucose levels. Moreover, serial transplantation revealed that these stable acinar-derived grafts could partially correct blood glucose levels when transplanted into a new diabetic recipient mouse.

Genetic lineage tracing based on acinar cell-specific expression of a fluorescent reporter revealed that human acinar cells can not only give rise to duct-like cells (previously documented^[@bib13]^) but also to cells expressing Neurog3 and insulin following the overexpression of MAPK and STAT3 in specific proendocrine culture conditions. A recent report demonstrated that human acinar cells in culture can give rise to insulin^+^ cells following introduction of Neurog3, Pdx1 and MafA followed by a series of (epigenetic) signaling events,^[@bib33]^ thus extrapolating the initial findings documented in mice *in vivo*.^[@bib34]^ The present report, however, is the first to show that human acinar cells can initiate proendocrine differentiation by activated signaling without the introduction of transcription factors and thus opening the possibility of inducing endocrine differentiation with a combination of growth factors.

Duct cells have previously been shown to harbor the potential for endocrine differentiation.^[@bib3],\ [@bib4],\ [@bib35]^ When ectopic Neurog3 is introduced in human duct cultures, these cells adopt an endocrine-like fate.^[@bib35]^ Lack of lineage tracing in this mixed exocrine population does not allow the assessment of potential acinar contribution to this phenomenon. Others reported that adherent culture of human duct cells using overlay matrigel coating generates insulin^+^ islets-like structures.^[@bib3],\ [@bib4]^ These starting preparations did not include lineage tracing, and follow-up studies using *β*-cell-depleted exocrine preparations failed to reproduce these findings.^[@bib5]^ Although the exocrine fractions used here initially contain a mixed population including mature duct cells, and human duct cells have previously been suggested to give rise to new *β* cells,^[@bib3],\ [@bib4]^ the absence of duct-specific lineage tracing does not allow us to speculate on the differentiation potential of human duct cells in the current study.

The number of Neurog3^+^ cells in MS^CA^ cells was substantial but the absolute amount of insulin^+^ cells remained low *in vitro*, even under the most optimal culture conditions tested. Short-term engraftment of these cells only modestly improved endocrine differentiation. We did observe increased expression of MafA in some of the *β*-like cells after short-term engraftment, suggesting improved *in vivo* maturation of the insulin^+^ cells rather than ongoing differentiation of exo- to endocrine cells. In contrast, long-term engraftment of MS^CA^ cells appeared to provoke a significant increase in human insulin^+^ cells, which are now organized in structures resembling islets. Interestingly, under these conditions, GFP expression seems to be enriched in *β*-like cells. This observation is suggestive of a preferential endocrine differentiation of MS^CA^ cells following more than 200 days *in vivo*. Moreover, not only did we observe an increase in *β*-like cell numbers, genetic lineage tracing also showed that more than 60% of these insulin^+^ cells originated from human acinar cells, compared with 30% of the duct-like population of the grafts.

The current report demonstrates for the first time that human acinar cells can adopt a *β*-like phenotype without the need to introduce a combination of pancreatic transcription factors. This acinoinsular reprogramming depends on 3D growth, activation of MAPK/STAT3 signaling and an intermediate Neurog3^+^ step. Given the volume of human acinar cells discarded upon clinical islet isolation, this approach may present an interesting strategy to increase the amount of transplantable *β* cells provided the efficiency of cell-type conversion can be improved and the involvement of viruses avoided.

Materials and Methods
=====================

Human exocrine cells
--------------------

Ethical approval to use exocrine-enriched cells derived from donor organs was given by the Medical Ethical Committee of the University Hospital of the Vrije Universiteit Brussel (Brussels, Belgium; OG 016) to the Beta Cell Bank-University Hospital Brussels (permission 2010/193). The human exocrine fraction was obtained from heart-beating cadaveric non-diabetic donors as the discarded fraction from islet cell isolation for the purpose of clinical transplantation in type 1 diabetes patients. Human donors aged between 18 and 67 years (median age=51 years) and had a male-to-female ratio of 1.3 (*n*=16). In the exocrine fraction, starting preparations contain \~60% acinar, 35% duct, 1--3% endocrine and 1--2% mesenchymal cells. After a culture period of at least 4 days, these preparations contain 1.5% of cells expressing endocrine cell markers and 90% expressing the duct cell-specific phenotypic markers Krt19 and carbohydrate antigen 19.9.^[@bib36]^

Animals
-------

All animal experimentations were performed in agreement with the regulations approved by the ethical committee of the Free University of Brussels. Eight-week-old NOD.CB17-*Prkdc*^*scid*^/NCrCrl or C.B-17/IcrHsd-PrkdcscidLystbg-J mice and BALB/cAnNCrl-*nu*BR nude mice (Charles River Laboratories, L\'Arberesle, France) weighing 22--28 g were used as recipients for transplantation.

Lineage tracing
---------------

Acinar lineage tracing was achieved by the combination of an adenovirus expressing Cre recombinase under the control of a 550 kb human pancreatic elastase 2A promoter fragment (Ad-*Cela-2A*^Cre^) and a lentivirus expressing either DsRed or LacZ preceded by a stop sequence flanked by loxP sites, under the control of the constitutive active CMV promoter (Le-CMV-LSL-DsRed/LacZ). This allows for indefinite labeling of acinar cells.

Experimental model
------------------

*β-*Cell neogenesis was induced in exocrine cell cultures after a differentiation period of 7 days monolayer culture, 7 days 3D matrix culture or a sequential period of 10 days suspension followed by 7 days 3D matrix. The matrix constitutes undiluted Matrigel Matrix Growth Factor Reduced (Matrigel GFR; BD Biosciences, San Jose, CA, USA). Human exocrine cells were transduced directly after isolation with lentiviruses expressing activated MAPK and STAT3. The cells were cultured in RPMI-1640 medium supplemented with 1% FBS (Life Technologies, Grand Island, NY, USA).

Reverse transcription-PCR
-------------------------

Total RNA was isolated using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA; 74106) and was transcribed and amplified as described by the manufacturer using blanks in each assay.

Quantitative PCR was performed using TaqMan Fast Universal PCR Master Mix (Applied Biosystems, Grand Island, NY, USA; 4364103) with selected primers ([Table 1](#tbl1){ref-type="table"}). Two replicate reactions were used for every sample. In addition, a positive control was used and all expression levels were normalized to the housekeeping gene *PPIA* (peptidylpropyl isomerase A or cyclophilin-A).^[@bib37]^ Nuclease-free water was run as a negative control.

Viral constructs
----------------

Constitutively active STAT3 was generated by site-directed mutagenesis using the primer 5′-GCTATAAGATCATGGATTGTACCTGCATCCTGGTGTCTCC-3′ (a kind gift from JE Darnell).^[@bib38]^ The STAT3^CA^ was ligated in a *Spe*I/*Xma*I-digested pTrip-CMV-eGFP-NheIpoly-invPGK vector generating pTrip-CMV-eGFP-NheIpoly-invPGK-STAT3^CA^. From the pTrip plasmid, a lentivirus production was started following the described protocol.

Constitutively active MAPK1 was generated by constructing a fusion between native ERK2 and MEK1, and subsequential mutation of four leucine residues in the export signal region to alanine, generating a hyperactivated MAPK1. The pG5E4D38-CMV5-MAPK^CA^ vector is a kind gift from Cobb and co-workers.^[@bib39]^ CMV-MAPK^CA^ was transferred to a pTrip vector by *Sal*I/*Nhe*I ligation, generating a pTrip-CMV-MAPK^CA^-ires-eGFP vector, which was used for lentivirus production.

Combining both single vectors to a single pTrip-CMV-MAPK^CA^-ires-eGFP-NheIpoly-invPGK- STAT3^CA^ vector generated a bicistronic vector expressing both MAPK^CA^ and STAT3^CA^.

Immunostaining
--------------

Immunocytochemistry was performed in 24-well plates. IHC was performed on paraffin sections.^[@bib36]^ The different antibodies used can be found in [Table 2](#tbl2){ref-type="table"}.

Microscopy
----------

All images were acquired with a Zeiss LSM710 NLO TiSa multiphoton confocal microscope using Zeiss Zen2011 software (Carl Zeiss NV-SA, Zaventem, Belgium). All pictures were analyzed with VolocityLE software (Improvision, Coventry, UK).

Transplantation
---------------

Cells were detached using 0.25% Collagenase-V (Sigma (St. Louis, MO, USA); 9001-12-1) for the monolayers. After exposing the left kidney, a small incision was made in the kidney capsule. The cells were collected in a catheter and delivered under the kidney capsule using a microdispenser pipet (Mitutoyo, Aurora, IL, USA). An average of 3 00 000 human exocrine cells was engrafted under the kidney capsule. Per human donor, three mice were engrafted and six independent donors were used for transplantation.

Metabolic studies
-----------------

Blood glucose levels were monitored in tail vein samples (Glucocard Memory Strips; A Menarini Diagnostics Benelux, Zaventem, Belgium). Mice were fasted during 6 h and injected intraperitoneally with glucose (2 g per kg body weight) for glucose tolerance tests, and blood glucose concentration was measured from tail vein blood with a portable glucometer. Plasma c-peptide concentration was determined with the Human C-peptide ELISA Kit (Millipore, Billerica, MA, USA). For GSIS analysis, pancreatic islets were isolated by collagenase digestion, handpicked and pooled. Secreted insulin levels were determined at low (2 h at 2.5 mM glucose) and high (2 h at 20 mM glucose) concentrations. The level was determined with the Human Insulin ELISA Kit (Millipore).

Statistical analysis
--------------------

GraphPad Prism version 5.0b was used to create the graphs and perform the statistics (GraphPad Prism, La Jolla, CA, USA). Results compared with their control set at 1 were analyzed using a one-sample Student\'s *t*-test. When two treatment groups were compared, a two-tailed Student\'s *t*-test was used. Mean values are presented as the mean±S.E.M. The number of independent experiments is indicated in the text. *N*-values represent independent human donors.
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PTF1A

:   pancreas-specific transcription factor 1a

PDX1

:   pancreatic and duodenal homeobox 1

NEUROG3
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MAPK

:   mitogen-activated protein kinase

STAT3

:   signal transducer and activator of transcription 3
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:   green fluorescent protein
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:   chymotrypsin-like elastase 2A
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![Schematic overviews of different culture systems. (**a** and **b**) Schematic overview of the monolayer culture system. (**a**) Transduction of human exocrine cells obtained from cadaveric donors with a lentivirus overexpressing activated MAPK and STAT3 (LeMS^CA^) and subsequent formation of adherent monolayer cultures. The cells are exposed to LeMS^CA^ for 24 h after which the excess virus is washed away. The cells are kept for 7 days in multiwall plates to allow monolayer formation. (**b**) Overexpression of MAPK^CA^ for 3 days before combined overexpression of MAPK^CA^ -STAT3^CA^ (LeM^CA^~3d~MS^CA^~7d~). The cells are exposed to Le-MAPK^CA^ for 24 h, followed by removal of the excess virus, and cells are kept in fresh medium for 2 more days. On the third day, the cells are transduced with Le-MAPK^CA^ -STAT3^CA^. The medium is changed after 24 h and the cells ate kept in multiwall plates with fresh medium for 7 days. To allow for potential further differentiation, the LeM^CA^~3d~MS^CA^~7d~ condition is transplanted under the kidney capsule of immunodeficient mice. The animals are kept for 42 days after which the graft-bearing kidney is removed and the graft is recovered for further analysis. (**c**--**e**) Schematic overview of the 3D, FF/3D and FF/*in vivo* culture systems. (**c**) Transduction of human exocrine cells with a lentivirus overexpressing activated MAPK and STAT3 and subsequent 3D Matrigel culture (LeMS^CA^~3D~). The cells are exposed to LeMS^CA^ for 24 h followed by removal of the excess virus. The cells are kept in 3D Matrigel for 8 days. (**d**) Transduction of human exocrine cells with a lentivirus overexpressing activated MAPK and STAT3 and subsequent free-floating/3D Matrigel culture (LeMS^CA^~FF/3D~). The cells are exposed to LeMS^CA^ for 24 h followed by removal of the excess virus. The cells are kept in free-floating culture for \~10 days after which they are transferred to 3D Matrigel for 8 days. (**e**) The free-floating cells (LeMS^CA^~FF~) are transplanted under the kidney capsule of immunodeficient mice to allow potential further differentiation. The animals are kept for 42 days after which the graft-bearing kidney is removed and the graft is recovered for further analysis. (**f**) Schematic overview of the acinar-specific genetic lineage tracing experiment. The human exocrine cells are exposed to the three viruses (Ad-Ela-Cre, Le-CMV-LSL-DsRed, LeMS^CA^) at the same time for 24 h after which the excess virus is removed. The cells are then kept in free-floating culture for \~10 days after which they are transferred to 3D Matrigel for 8 days](cdd2014193f1){#fig1}

![Overexpression of MAPK^CA^ and STAT3^CA^ promotes endocrine differentiation *in vitro*. (**a** and **c**) Gene expression profile of endocrine markers (**a**), acinar markers (**b**) and ductal markers (**c**). LeMS conditions are normalized to control conditions (LeGFP) set at 1 (red line). *Protocol 1*: Original protocol with 7-day combined STAT3^CA^/MAPK^CA^ (LeMS^CA^) (*n*=6; \**P*\<0.05; \*\**P*\<0.01). *Protocol 2*: Sequential treatment with 3-day MAPK^CA^ followed by 7-day combined STAT3^CA^/MAPK^CA^ (LeM^CA^~3d~MS^CA^~7d~) (*n*=9; \**P*\<0.05; \*\**P*\<0.01). Endocrine genes *INS*, *PDX1* and *NKX6.1* are significantly upregulated in protocol 2, whereas exocrine genes *MIST1* and *FOXA2* were downregulated compared with protocol 1. The trend on endocrine genes combined with the increase in *ONECUT1* transcripts suggests an accelerated endocrine differentiation in protocol 2. (**d**) Immunocytochemical analysis of Neurog3 and insulin expression after the original 7-day protocol (LeMS^CA^) and the sequential 3-day MAPK^CA^ followed by 7-day combined STAT3^CA^/MAPK^CA^ (LeM^CA^~3d~MS^CA^~7d~). Neurog3^+^ cells were readily detected in LeMS^CA^ and the fraction of Ngn3-expressing cells slightly increased in LeM^CA^~3d~MS^CA^~7d~. No insulin^+^ cells could be detected in LeMS^CA^ or LeM^CA^~3d~MS^CA^~7d~. (**e**) Immunocytochemical analysis of Pdx1 and Neurog3 after LeMS^CA^ and LeM^CA^~3d~MS^CA^~7d~. The number of Pdx1-expressing cells is markedly increased in LeM^CA^~3d~MS^CA^~7d~ compared with the LeMS^CA^ condition. The majority of the Pdx1^+^ cells coexpress Neurog3. (**f**) Quantification of the proportion of transduced cells (EGFP^+^) expressing Neurog3 or Pdx1. The increase in the percentage of Neurog3^+^ is comparable in both protocols (40±2% in LeM^CA^~3d~MS^CA^~7d~ *versus* 38±1% in LeMS^CA^; *n*=4; *P*\>0.05); however, an increase can be detected in the percentage of PDX1^+^ cells with LeM^CA^~3d~MS^CA^~7d~ compared with LeMS^CA^ (28±3% in LeM^CA^~3d~MS^CA^~7d~ *versus* 8±1% in LeMS^CA^; *n*=4; \**P*\<0.05; \*\**P*\<0.01)](cdd2014193f2){#fig2}

![Engraftment of LeMCA3dMSCA7d monolayer-cultured human exocrine cells allows for *in vivo* maturation. (**a**--**c**) Immunohistochemical analysis of the graft-bearing kidney of immunodeficient mice transplanted with the human cells transduced with LeM^CA^~3d~MS^CA^~7d~. (**a**) In contrast to the *in vitro* cultures, a near total loss of Ngn3 expression is observed after transplantation of the LeM^CA^~3d~MS^CA^~7d~ cells, whereas Pdx1 remains detectable in the majority of the epithelial cells. Bar: 35 *μ*m. (**b** and **c**) All transplanted human cells remain Krt19^+^, except for the hormone^+^ cells. (**b**) Gcg^+^ cells were detected dispersed within the transplanted epithelial cells. (**c**) Following transplantation, insulin^+^ cells appear within the graft. When analyzing the *β*-cell marker MafA, we observed only few insulin^+^ cells coexpressing MafA, indicative of their immature nature. (**d**) Quantification of the protein expression after the transduction protocol LeM^CA^~3d~MS^CA^~7d~ before transplantation (*in vitro*) and after 42 days under the kidney capsule (*in vivo*). The most striking observation is the appearance of insulin^+^ cells after *in vivo* transplantation combined with the disappearance of Neurog3^+^ cells. Gcg, glucagon](cdd2014193f3){#fig3}

![Overexpression of MAPK^CA^ and STAT3^CA^ promotes re-expression of Ngn3 and Pdx1 and endocrine differentiation in 3D matrix cultures *in vitro*. (**a** and **b**) Gene expression profile of endocrine (**a**) and exocrine markers (**b**). LeMS conditions are normalized to control conditions (LeGFP) set at 1 (red line). In LeMSCA3D condition, we observed a significant increase in *NEUROD* and *NEUROG3* transcripts compared with controls. These observations were mirrored in the LeMS^CA^~FF/3D~ condition with additional increase in *INS*, *NKX6.1* and *ISL1* transcripts. Both the ~LeMSCA3D~ and LeMS^CA^~FF/3D~ condition showed a modest but significant increase in *PTF1A* transcripts (*n*=5) (\**P*\<0.05; \*\**P*\<0.01). (**c**--**e**) Immunocytochemical analysis after 3D culture (~LeMSCA3D~) and the free-floating culture followed by 3D culture (LeMS^CA^~FF/3D~). (**c**) Both in the ~LeMSCA3D~ and LeMS^CA^~FF/3D~ condition, Neurog3^+^ cells can be detected in transduced (EGFP^+^) cells. The majority of these Ngn3^+^ cells coexpress the ductal marker Krt19. Cells expressing Neurog3 protein were never observed in the corresponding control conditions (LeGFP~3D~ and LeGFP~FF/3D~). (**d**) In the ~LeMSCA3D~ and LeMS^CA^~FF/3D~ condition, cells expressing high levels of Pdx1 protein can be detected. A fraction of these cells displayed coexpression with Neurog3. Cells expressing high Pdx1 protein were only rarely observed in the corresponding control conditions (LeGFP~3D~ and LeGFP~FF/3D~). (**e**) LeMS^CA^~3D~ and LeMS^CA^~FF/3D~ conditions show for the first time the presence of INS^+^ cells *in vitro*. These insulin^+^ cells do not express the ductal marker Krt19. (**f**) Quantification of the proportion of cells expressing the different phenotypical markers. A significant increase in the number of insulin^+^ cells can be observed in the LeMS^CA^~FF/3D~ condition (7.3±2.6% in LeMS^CA^~FF/3D~ (*n*=7) *versus* 0.83±0.40% in ~LeMSCA3D~ (*n*=8) and 0.06±0.06% in LeGFP~FF/3D~ (*n*=10); \**P*\<0.05; \*\**P*\<0.01). The percentage of Neurog3^+^ and Pdx1^+^ cells is significantly increased in both ~LeMSCA3D~ and LeMS^CA^~FF/3D~ conditions compared with controls (\**P*\<0.05; \*\*\**P*\<0.001)](cdd2014193f4){#fig4}

![Short-term transplantation of LeMSCAFF cells yields a limited number of insulin+ cells. (**a** and **c**) Immunohistochemical analysis of LeMS^CA^~FF~ human exocrine cells following 42-day engraftment under the kidney capsule of immunodeficient mice. (**a**) In contrast to the cell preparation before transplantation, insulin^+^ cells can be observed in LeMS^CA^~FF~ condition after engraftment *in vivo*. LeGFP~FF~ controls never showed an increase in the fraction of insulin^+^ cells (**b**) Pdx1 expression is prominent in the majority of the Krt19^+^ epithelial cells both in LeGFP~FF~ and LeMS^CA^~FF~ conditions (the latter contains more cells with high Pdx1 expression). However, compared with the cell preparation before transplantation, we observed a near total loss of Neurog3^+^ cells after engraftment in the LeMS^CA^~FF~ condition. LeGFP~FF~ conditions never show Neurog3^+^ cells. (**c**) Hormone^+^ cells (INS^+^ or Gcg^+^) do not express the ductal marker Krt19. (**d**) Quantification of the fraction of cells expressing insulin, Neurog3 or high levels of Pdx1 protein in LeGFP~FF~ and LeMS^CA^~FF~ conditions. A significant increase in the number of insulin- and Pdx1-expressing cells could be observed in the transplanted LeMS^CA^~FF~ condition (5.6±1.1% insulin+ cells (*n*=10); 4.2±0.7% Pdx1+ cells (*n*=5); \*\*\**P*\<0.001). Gcg, glucagon](cdd2014193f5){#fig5}

![Genetic lineage tracing of human acinar cells reveals acinar to *β-*cell transdifferentiation To trace the fate of adult human acinar cells in our culture system, the cells were transduced with Cre recombinase under the control of the acinar-specific elastase 2 A promoter and the reporter construct CMV-LSL-nls-DsRed. (**a**) Original acinar cells identified by the presence of the DsRed fluorescent protein were readily detected in both LeGFP~FF/3D~ and LeMS^CA^~FF/3D~ conditions. However, insulin^+^/DsRed^+^ cells were only detected in LeMS^CA^~FF/3D~ condition but never in the LeGFP~FF/3D~ control. Every insulin^+^/DsRed^+^ cell in the latter condition also contained the GFP label, indicative of transduction with MAPK^CA^-STAT3^CA^. (**b**) Neurog3^+^ cells containing the acinar lineage tracer DsRed were observed in the LeMS^CA^~FF/3D~ condition only, as Neurog3^+^ cells were never detected in the control condition](cdd2014193f6){#fig6}

![Long-term engraftment generates acinar-derived islet-like clusters *in vivo*. (**a**) Circulating human c-peptide levels in mice engrafted with either LeGFP~FF~ or LeMS^CA^~FF~ cells. Significantly increased levels of c-peptide are detected in LeMS^CA^~FF~ mice from day 90 postengraftment. C-peptide levels become stable around day 148 (0.30±0.02 ng/ml in LeMS^CA^~FF~ *versus* 0.08±0.02 ng/ml in LeGFP~FF~; *P*\<0.01, *n*=6). After alloxan injection, c-peptide levels in LeMS^CA^~FF~ mice further increased to 0.38±0.02 ng/ml. No human c-peptide could be detected after nephrectomy of the graft-bearing kidney at day 210. (**b**) Blood glucose levels in mice engrafted with either LeGFP~FF~ or LeMS^CA^~FF~ cells. Before alloxan injection, both groups are indistinguishable (on day 190, 6.3±0.2 mmol/l in LeMS^CA^~FF~ *versus* 5.8±0.2 mmol/l in LeGFP~FF~; *P*\>0.05, *n*=6). After alloxan injection, blood glucose levels of LeMS^CA^~FF~ mice remain significantly lower compared with LeGFP mice (on day 206, 16.6±0.5 mmol/l in LeMS^CA^~FF~ *versus* 32.7±0.3 mmol/l in LeGFP~FF~; *P*\<0.01, *n*=6). Removal of the graft-bearing kidney provoked an acute reversal to hyperglycemia in LeMS^CA^~FF~ mice (on day 212, 31.9±0.6 mmol/l *versus* 33.0±0.2 mmol/l in LeGFP~FF~; *P*\<0.01, *n*=6). (**c**) Intraperitoneal glucose tolerance test (IPGTT). Two micrograms of glucose per kg body weight was injected and clearance in blood was measured at indicated time points to indirectly measure the glucose responsiveness of insulin secretion by *β* cells (\**P*\<0.05; *n*=6 each). (**d**) Two hundred and ten days after engraftment of LeMS^CA^~FF~ cells results in stable grafts visualized by GFP expression. (**e**) Immunohistochemical analyses showed an increased fraction of insulin^+^ cells in LeMS^CA^~FF~ conditions to almost 10%. Whereas GFP was detected in only 30% of the Krt19^+^ cells at the time of analysis, GFP was found in over 60% of the insulin^+^ cells, indicating a preferential differentiation of LeMS^CA^~FF~-transduced cells to a *β*-like phenotype. Genetic lineage tracing using the acinar-specific elastase 2A promoter and the reporter construct CMV-LSL-LacZ revealed that 61% of the insulin^+^ cells originated from acinar cells, whereas the same holds true for 30% of the Krt19^+^ cells. (**f**) LeGFP~FF~ control grafts lacked expression of insulin+ cells but many cells expressed both GFP and *β*-galactosidase (*β*gal) demonstrating acinoductal metaplasia. LeMS^CA^~FF~ grafts, however, contained clusters of cells devoid of Krt19 expression while clearly positive for GFP and the acinar-specific *β*gal label. Closer examination demonstrated the expression of insulin and Pdx1 in these LeMS^CA^~FF~ *β*-like cells (scale bars=100 *μ*m, 25 *μ*m and 30 *μ*m)](cdd2014193f7){#fig7}

###### List of primer sequences

  **Gene**      **Primer reference**   **Source**
  ------------- ---------------------- --------------------
  *NEUROG3*     Hs56a19734677          IDT
  *PAX4*        Hs00173014_m1          Applied Biosystems
  *INS*         Hs56a21254175          IDT
  *NKX6.1*      Hs00232355_m1          Applied Biosystems
  *NKX2.2*      Hs00159616_m1          Applied Biosystems
  *PDX1/IPF1*   Hs00236830_m1          Applied Biosystems
  *HLXB9*       Hs00232128_m1          Applied Biosystems
  *GCG*         Hs00174967_m1          Applied Biosystems
  *MAFA*        Hs01651425_s1          Applied Biosystems
  *NEUROD*      Hs00159598_m1          Applied Biosystems
  *ISL1*        Hs00158126_m1          Applied Biosystems
  *PTF1a*       Hs00603586_g1          Applied Biosystems
  *MIST1*       Hs56a21101745          IDT
  *AMYLASE*     Hs56a38779302          IDT
  *ELASTASE*    Hs56a24621883          IDT
  *TCF2*        Hs56a25568705          IDT
  *SOX9*        Hs56a38984663          IDT
  *CK19*        Hs01051611_gH          Applied Biosystems
  *ONECUT1*     Hs00413554_m1          Applied Biosystems
  *CA2*         Hs00163869_m1          Applied Biosystems
  *CFTR*        Hs00357011_m1          Applied Biosystems
  *PPIA*        Hs39a22214851          IDT

###### List of primary antibodies

  **Antibody**   **Description**           **Source**
  -------------- ------------------------- -------------------------------
  GFP            Goat anti-GFP-biotin      Abcam (Cambridge, MA, USA)
  Neurog3        Rabbit anti-Ngn3          M German
  Ins            Guinea-pig anti-insulin   C Van Schravendijk
  CK19           Mouse anti-CK19           Dako (Glostrup, Germany)
  MafA           Rabbit anti-MafA          A Rezania
  Gcg            Mouse anti-glucagon       Sigma
  Pdx1           Guinea-pig anti-Pdx1      C Wright
  DsRed          Rabbit anti-RFP           Abcam
  Chymo          Rabbit anti-Chymo         Millipore
  Sox9           Rabbit anti-Sox9          Chemicon (Billerica, MA, USA)

[^1]: Senior authors.
